• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Lot Number 03968H25
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/25/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a balloon rupture occurred.The target lesion was located in the severely calcified superficial femoral artery.A 6.0 x 60 mm 200cm ranger drug coated balloon was advanced for dilation.However, during inflation, the balloon ruptured at 5-6 atmospheres.The device was removed without any problem, and the procedure was completed with a different device.There were no patient complications as a result of this event.
 
Additional Manufacturer Narrative
B5.Describe event or problem: added information, based on additional information.
 
Event or Problem Description
It was reported that a balloon rupture occurred.The target lesion was located in the severely calcified superficial femoral artery.A 6.0 x 60 mm 200cm ranger drug coated balloon was advanced for dilation.However, during inflation, the balloon ruptured at 5-6 atmospheres.The device was removed without any problem, and the procedure was completed with a different device.There were no patient complications as a result of this event.It was further reported that the target lesion was 90% stenosed and mildly tortuous.The balloon ruptured upon second inflation for 5 seconds, and the device was simply pulled out.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key23151374
Report Number2124215-2025-67839
Device Sequence Number21486873
Product Code ONU
UDI-Device Identifier00191506046767
UDI-Public(01)00191506046767
Combination Product (Y/N)Y
Initial Reporter CountryJA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/03/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Lot Number03968H25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/03/2025
Supplement Date Received by Manufacturer10/08/2025
Initial Report FDA Received Date09/25/2025
Supplement Report FDA Received Date11/03/2025
Date Device Manufactured04/09/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-